We are hardly two weeks into 2021, and shares of Relmada Therapeutics Inc. (RLMD) have gained 22% so far this year.
Shares of Aurinia Pharmaceuticals Inc. (AUPH) have fallen nearly 35% from their 52-week high of $20.48 recorded on Feb.21, 2020, and trade around $13.
Gracell Biotechnologies is scheduled to make its debut on the Nasdaq Global Select Market today (January 8), under the ticker symbol "GRCL."
The Suzhou, China-based Gracell Biotechnologies is a global clinical-stage biopharmaceutical company developing CAR-T cell therapies for cancer through its proprietary technology platforms—FasTCAR and TruUCAR.
Cullinan Management is scheduled to make its debut on the Nasdaq Global Select Market today (January 8), under the ticker symbol "CGEM."
Cambridge, Massachusetts-based Cullinan Management, Inc., which was founded in 2016, is a biopharmaceutical company developing oncology and immuno-oncology therapies with transformative potential for cancer patients.
Shares of Adamas Pharmaceuticals Inc. (ADMS) have recovered 140% from their 52-week low of $1.90 recorded on Mar.18, 2020, and trade around $4.50. Given the strong GOCOVRI sales, improving Namzaric royalties, and the upcoming FDA decision, Adamas is a stock worth following.
Shares of Aprea Therapeutics Inc. (APRE) have halved in value from their 52-week high of $53.11, recorded on Dec.30, 2019, and currently trade around $25.
Silverback Therapeutics Inc., a clinical-stage biopharmaceutical company developing systemically delivered, tissue targeted therapeutics for the treatment of cancer and other chronic viral infections, is scheduled to hit the Nasdaq Global Select Market on December 4, under the symbol "SBTX".
Kinnate Biopharma Inc., a biopharmaceutical company developing drugs for difficult-to-treat, genomically defined cancers, is all set to make its debut on the Nasdaq Global Select Market on December 3, under the symbol "KNTE".
The IPO activity in the U.S. healthcare sector has had a strong showing this year, with 87 listings between January and October. There have been no IPOs so far this month and two healthcare firms are expected to go public on November 20.
Shares of Twist Bioscience Corp. (TWST) closed at an all-time high of $102.16 on Wednesday, and that represents a five-fold increase in value year-to-date.
The following are the healthcare companies that are set for market debut this week.
Shares of Eiger BioPharmaceuticals Inc. (EIGR) are down 44 percent from their 52-week high of $15.82, recorded on December 26, 2019, and trade around $8.00.
The number of healthcare firms that have gone public on the U.S. stock exchanges so far this month is 17.
Let's take a look at the IPOs scheduled for Friday (Oct 30).
In the healthcare sector, 17 companies have made their debut on the NASDAQ so far this month.
Let's take a look at the U.S. healthcare IPOs scheduled for the week.